TD Cowen Raises MetLife (MET) Price Target to $114

MetLife, Inc. (MET) business photo

Key Points

  • TD Cowen reiterated its Buy rating on MetLife on October 21, 2026, lifting its price target to $114.00 from $110.00.
  • TD Cowen's $114 price target implies 12.67% upside from MetLife, Inc.'s ($MET) current $101.18 share price.
  • MetLife recently traded around $101.18, sitting below its 52-week high of $102.43 and ahead of its upcoming earnings report scheduled for November 4, 2026.
  • The company maintains a consensus Buy recommendation across Wall Street with a mean price target of $107.38.

Get MetLife text alerts

We text you when insiders, Congress, analysts or big funds move on $MET.

By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.

Not investment advice. TradeTexts is not a registered investment adviser, and this automated MetLife, Inc. alert may contain errors. Disclosures

On October 21, 2026, TD Cowen maintained its Buy rating on MetLife, Inc. (NYSE:MET) while lifting its price target from $110.00 to $114.00. The research note was issued on a day when MetLife closed at $102.11, while the stock recently traded at $101.18. TD Cowen's new target sits among the higher expectations for the insurer on Wall Street.

MET MetLife, Inc.
$99.58 +26.61% year to date
Daily close · Oct 19, 2026
Analyst rating track record

TD Cowen vs. the S&P 500

YTD return +4.78% hypothetical
All-time return +4.78% S&P 500 +1.48%
vs. S&P 500 +3.30% ahead of the index

Hypothetical returns from TD Cowen's disclosed trades, not real profit or advice. How we model this.

TD Cowen's Call on MetLife, Inc.

In its research note published on October 21, 2026, TD Cowen kept a Buy rating on MetLife shares and bumped up its target by $4.00 to $114.00. The forward-looking call reflects the firm's outlook on the financial services provider as it heads toward its next round of financial results.

Other Institutional Activity in MetLife, Inc.

Other large funds have also adjusted their positions in the insurer recently. TD Waterhouse Canada grew its holdings by 215,666 shares, ending with 373,636 shares worth about $35,279,556. TCV Trust & Wealth Management picked up a new stake of 2,491 shares valued at about $234,551. Meanwhile, Dodge & Cox Inc. reduced its position by 2,683,520 shares to hold 48,431,150 shares worth roughly $4,945,062,733. Pzena Investment Management LLC trimmed its stake by 172,950 shares, finishing the period with 11,130,983 shares valued at about $1,136,529,056.

MetLife, Inc. Stock Up 0.4%

MetLife shares recently traded around $101.18, putting the stock down about 0.9% from its closing price of $102.11 on the day of TD Cowen's update. The recent price sits 4.4% above its 50-day moving average of $96.91 and 19.4% above its 200-day moving average of $84.73. The stock trades just 1.2% below its 52-week high of $102.43 and 50.3% above its 52-week low of $67.33.

12-month forecast

$MET price target

MetLife, Inc. daily closes and this analyst's $114 target. Not advice.

Recent Earnings

MetLife reported trailing twelve-month revenue of $79.40 billion alongside earnings of $5.16 per share. The company generated a net profit margin of 4.6% and a return on equity of 13.1%. Investors look toward the company's upcoming earnings report on November 4, 2026, for further financial updates.

Dividend

MetLife pays an annual dividend of $2.37 per share, which translates to a dividend yield of 2.38%. The payout ratio stands at 44.0%, meaning the company uses less than half of its earnings to support the dividend payment.

Analysts Set New Price Targets

Other Wall Street firms have updated their outlooks on the insurer in recent weeks. Mizuho maintained its Outperform rating while lowering its target from $112.00 to $109.00 on October 7, 2026. Barclays kept an overweight rating and raised its target from $97.00 to $111.00 on October 7, 2026. Wells Fargo maintained an overweight rating and moved its target from $109.00 to $110.00 on October 12, 2026. JP Morgan maintained an overweight rating and raised its target from $108.00 to $110.00 on October 15, 2026. Across the street, the stock holds a consensus Buy recommendation with a mean price target of $107.38.

About MetLife, Inc.

MetLife is a New York-based financial services company that provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six main business segments: Group Benefits, Retirement and Income Solutions, Asia, Latin America, Europe, the Middle East and Africa, and MetLife Holdings.

Bottom Line

TD Cowen's decision to raise its price target comes as MetLife trades near its 52-week high. Investors will monitor the company's upcoming earnings report on November 4, 2026, to see how business segments are performing.

Source: TD Cowen's rating change on $MET (Oct 21, 2026). Written by software, not financial advice. How we make alerts

Get $MET trade alerts by text

SMS Terms

By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.

Full terms and conditions